Code | CSB-YP026133HU |
Abbreviation | Recombinant Human WNT2 protein |
MSDS | |
Size | $250 |
Order now | |
Image | |
Have Questions? | Leave a Message or Start an on-line Chat |
The first step of making this recombinant Human WNT2 protein is synthesizing the WNT2 gene, the synthesized gene is then cloned into an expression vector which is a cDNA plasmid that includes a promoter sequence and an antibiotic-resistant gene. It also has N-terminal 6xHis tag encoding a fusion tag for downstream protein purification or identification. The antibiotic-resistant gene enables the selection of cells carrying the plasmid in antibiotic-based media and then transfects cells with a DNA vector that contains the template and then culturing the cells so that they transcribe and translate the desired protein. The recombinant WNT2 protein is purified by ion-exchange chromatography or affinity purification. And the purity is 90%+ by SDS-PAGE.
WNT2 is an autocrine growth and differentiation factor specific for hepatic sinusoidal endothelial cells (HSECs), which act synergistically with the VEGF signaling pathway. Studies have shown that targeted disruption of the WNT2 gene causes placental defects. WNT2 has been implicated in the occurrence and progression of multiple human malignancies, including lung, breast, and colorectal cancers. WNT2 expression was found to be upregulated in human colorectal and gastric cancers, while WNT2 short interfering RNA (siRNA) or monoclonal antibodies can suppress tumor growth. WNT2 regulates beta-catenin localization in granulosa cells, and WNT2/-catenin signaling helps modulate granulosa cell proliferation.There are currently no reviews for this product.